The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Update on Key Emerging Challenges in Cystic Fibrosis
Open accessAbstract
Cystic fibrosis (CF) is a multisystem disease causing severe chronic sinopulmonary disease and loss of pancreatic exocrine function, which affects approximately 70,000 individuals worldwide. New therapeutic developments over the last few decades have resulted in a significant increase in survival, with the median predicted survival now reaching the late thirties and more and more CF patients living well into adulthood. However, with this advent of new therapies and the associated increase in survival, new challenges in CF care have also emerged. Two of these challenges, i.e. chronic methicillin-resistant Staphylococcus aureus lung infection and patient adherence to very complicated and time-consuming therapeutic regimens, are reviewed in detail here. In addition, the ultimate challenge of treating the underlying cause of CF by correcting the dysfunction of the CF transmembrane conductance regulator chloride channel is reviewed, as agents to correct channel function will likely significantly alter CF clinical outcomes and treatment approaches in the next decade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Webb, A. K. (2006) · Cited by 4,369
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., Dřevínek, P., Griese, M., McKone, E. F., Wainwright, C. E., Konstan, M. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105185 · Cited by 2,195
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Interventions for enhancing medication adherence
Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub3 · Cited by 1,244
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
PTC124 targets genetic disorders caused by nonsense mutations
Welch, E. M., Barton, E. R., Zhuo, J., Tomizawa, Y., Friesen, W. J., Trifillis, P., Paushkin, S., Patel, M., Trotta, C. R., Hwang, S., et al. (2007) · Nature · doi:10.1038/nature05756 · Cited by 1,137
Cystic Fibrosis Pulmonary Guidelines: Chronic Medications for Maintenance of Lung Health
Flume, P. A., O'Sullivan, B. P., Robinson, K. A., Goss, C. H., Mogayzel, P. J., Willey-Courand, D. B., Bujan, J., Finder, J., Lester, M., Quittell, L., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-664oc · Cited by 1,024
Research works printed but not linked: 5
- 10.1016/j.jcf.2009.11.009 · doi:10.1016/j.jcf.2009.11.009
- 10.1016/j.jhin.2003.12.003 · doi:10.1016/j.jhin.2003.12.003
- 10.1002/ppul.10231 · doi:10.1002/ppul.10231
- 10.1002/ppul.21315 · doi:10.1002/ppul.21315
- 10.1016/S0140-6736(12)60617-5 · doi:10.1016/s0140-6736(12)60617-5
Cited by
Items 201–234 of 234
Mutation-specific downregulation of CFTR2 variants by gating potentiators
Avramescu, R. G., Kai, Y., Xu, H., Bidaud-Meynard, A., Schnúr, A., Frenkiel, S., Matouk, E., Veit, G., & Lukacs, G. L. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx367 · Cited by 43
Drake, R. J., Nordentoft, M., Haddock, G., Arango, C., Fleischhacker, W. W., Glenthøj, B., Leboyer, M., Leucht, S., Leweke, M., McGuire, P., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv015 · Cited by 42
Edmondson, D., Falzon, L., Sundquist, K. J., Julian, J., Meli, L., Sumner, J. A., & Kronish, I. M. (2018) · Behaviour Research and Therapy · doi:10.1016/j.brat.2017.10.001 · Cited by 39
Self-management education for cystic fibrosis
Savage, E., Beirne, P. V., Ni Chroinin, M., Duff, A., Fitzgerald, T., & Farrell, D. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007641.pub3 · Cited by 38
Norman, J., Fu, M., Ekman, I., Björck, L., & Falk, K. (2018) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515117715843 · Cited by 36
Abbott, J., & Gee, L. (2003) · Pediatric Drugs · doi:10.2165/00128072-200305010-00004 · Cited by 36
Putman, M. S., Norris, A. W., Hull, R. L., Rickels, M. R., Sussel, L., Blackman, S. M., Chan, C. L., Ode, K. L., Daley, T., Stecenko, A. A., et al. (2023) · Diabetes Care · doi:10.2337/dc23-0380 · Cited by 35
The role of psychological science in efforts to improve cardiovascular medication adherence.
Bosworth, H. B., Blalock, D. V., Hoyle, R. H., Czajkowski, S. M., & Voils, C. I. (2018) · American Psychologist · doi:10.1037/amp0000316 · Cited by 35
Taylor, J. H., Xu, Y., Li, F., Shaw, M., Dziura, J., Caprio, S., Tamborlane, W. V., Nowicka, P., & Savoye, M. (2017) · Pediatric Obesity · doi:10.1111/ijpo.12165 · Cited by 34
Pader, V., James, E. H., Painter, K. L., Wigneshweraraj, S., & Edwards, A. M. (2014) · Infection and Immunity · doi:10.1128/iai.02254-14 · Cited by 32
Nelson, C. J., Saracino, R. M., Napolitano, S., Pessin, H., Narus, J. B., & Mulhall, J. P. (2019) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2019.05.013 · Cited by 30
Eating disorders and body image in cystic fibrosis
Darukhanavala, A., Merjaneh, L., Mason, K., & Le, T. (2021) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2021.100280 · Cited by 27
Schaper, N. C., Nikolajsen, A., Sandberg, A., Buchs, S., & Bøgelund, M. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0317-9 · Cited by 27
Hoo, Z. H., Curley, R., Campbell, M. J., Walters, S. J., Hind, D., & Wildman, M. J. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s105530 · Cited by 27
Sibeko, G., Temmingh, H., Mall, S., Williams-Ashman, P., Thornicroft, G., Susser, E. S., Lund, C., Stein, D. J., & Milligan, P. D. (2017) · BMC Research Notes · doi:10.1186/s13104-017-2915-z · Cited by 26
Verkleij, M., Georgiopoulos, A. M., & Friedman, D. (2021) · Internet Interventions · doi:10.1016/j.invent.2021.100372 · Cited by 26
Kröger, E., Tatar, O., Vedel, I., Giguère, A. M. C., Voyer, P., Guillaumie, L., Grégoire, J.-P., & Guénette, L. (2017) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-017-0487-6 · Cited by 23
Psihogios, A. M., Li, Y., Butler, E., Hamilton, J., Daniel, L. C., Barakat, L. P., Bonafide, C. P., & Schwartz, L. A. (2019) · JMIR mhealth and uhealth · doi:10.2196/12547 · Cited by 24
Variable cellular ivacaftor concentrations in people with cystic fibrosis on modulator therapy
Guimbellot, J. S., Ryan, K. J., Anderson, J. D., Liu, Z., Kersh, L., Esther, C. R., Rowe, S. M., & Acosta, E. P. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2020.01.011 · Cited by 24
Oren, E., Bell, M. L., Garcia, F., Perez-Velez, C., & Gerald, L. B. (2017) · Pilot and Feasibility Studies · doi:10.1186/s40814-017-0128-9 · Cited by 20
Granger, E., Davies, G., & Keogh, R. H. (2022) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.08.014 · Cited by 21
Can older people remember medication reminders presented using synthetic speech?
Wolters, M. K., Johnson, C., Campbell, P. E., DePlacido, C. G., & McKinstry, B. (2015) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002820 · Cited by 17
The Use of Home Spirometry in Pediatric Cystic Fibrosis Patients: Results of a Feasibility Study
Shakkottai, A., & Nasr, S. Z. (2017) · Global Pediatric Health · doi:10.1177/2333794x17690315 · Cited by 16
Bruxvoort, K., Kalolella, A., Cairns, M., Festo, C., Kenani, M., Lyaruu, P., Kachur, S. P., Schellenberg, D., & Goodman, C. (2015) · Malaria Journal · doi:10.1186/s12936-015-0602-x · Cited by 16
DeepRisk: a deep learning approach for genome-wide assessment of common disease risk
Peng, J., Bao, Z., Li, J., Han, R., Wang, Y., Han, L., Peng, J., Wang, T., Hao, J., Wei, Z., et al. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.02.015 · Cited by 15
Szczesniak, R. D., Brokamp, C., Su, W., Mcphail, G. L., Pestian, J., & Clancy, J. P. (2019) · IEEE Journal of Translational Engineering in Health and Medicine · doi:10.1109/jtehm.2018.2878534 · Cited by 15
Dawson, S., Girling, C.-J., Cowap, L., & Clark-Carter, D. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013766.pub2 · Cited by 14
Cuffee, Y. L., Sciamanna, C., Gerin, W., Lehman, E., Cover, L., Johnson, A. A., Pool, A., & Yang, C. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpy160 · Cited by 11
Sharp, L. K., Biggers, A., Perez, R., Henkins, J., Tilton, J., & Gerber, B. S. (2021) · JMIR Research Protocols · doi:10.2196/17170 · Cited by 11
Nurjadi, D., Chanthalangsy, Q., Zizmann, E., Stuermer, V., Moll, M., Klein, S., Boutin, S., Heeg, K., & Zanger, P. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01510-21 · Cited by 10
Genome mining yields putative disease-associated ROMK variants with distinct defects
(2023) · doi:10.1371/journal.pgen.1011051 · Cited by 7
Survival difference between high-risk and low-risk CFTR genotypes after lung transplant
Clausen, E. S., Weber, J. M., Neely, M. L., Ramos, K. J., & Snyder, L. D. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.04.009 · Cited by 5
MicroRNA-33 inhibition ameliorates muscular dystrophy by enhancing skeletal muscle regeneration
Sowa, N., Horie, T., Ide, Y., Baba, O., Kora, K., Yoshida, T., Nakamura, Y., Matsumura, S., Matsushita, K., Imanaka, M., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00273-9 · Cited by 4
Shin, J., Jang, J., & Afaya, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-060590 · Cited by 2
Metadata
- Authors
- Jennings, M. T., Riekert, K. A., & Boyle, M. P.
- Venue
- Medical Principles and Practice
- Publisher
- S. Karger AG
- Published
- 2014
- Volume
- 23
- Issue
- 5
- Pages
- 393-402
- ISSN
- 1011-7571 (ISSN-L)
- 1423-0151
- OpenAlex
- W2078078890
- Cited by
- 3,648
- References
- 81
- FWCI
- 259.52
- Type
- journal article
- Language
- en
- Open access
- diamond
- Licence
- creativecommons.org/licenses/by-nc/3.0/ (vor)
- creativecommons.org/licenses/by-nc/3.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.